Skip to content

Organon OGN Restructuring Reserve

Restructuring Reserve at other companies

Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$0
Biogen logo
BiogenBIIB
Viatris logo
ViatrisVTRS

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:RestructuringReserve.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's restructuring reserve.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's restructuring reserve?
Organon (OGN) reported restructuring reserve of $32M in Q1 2026.
How has Organon's restructuring reserve changed year-over-year?
Organon's restructuring reserve decreased by 64.8% year-over-year, from $91M to $32M.
What is the long-term trend for Organon's restructuring reserve?
Over 5 years (2020 to 2025), Organon's restructuring reserve has grown at a -14.0% compound annual growth rate (CAGR), from $17M to $8M.
What does restructuring reserve mean?
This represents the estimated liability for costs associated with formal restructuring plans, such as severance, facility closures, or asset impairments. It reflects management's commitment to operational efficiency and strategic realignment. These reserves are drawn down as the restructuring activities are executed.